ZA921039B - New pharmaceutical use of fused tetrahydropyridine derivatives - Google Patents
New pharmaceutical use of fused tetrahydropyridine derivativesInfo
- Publication number
- ZA921039B ZA921039B ZA921039A ZA921039A ZA921039B ZA 921039 B ZA921039 B ZA 921039B ZA 921039 A ZA921039 A ZA 921039A ZA 921039 A ZA921039 A ZA 921039A ZA 921039 B ZA921039 B ZA 921039B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical use
- new pharmaceutical
- tetrahydropyridine derivatives
- fused tetrahydropyridine
- fused
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4104257A DE4104257A1 (en) | 1991-02-13 | 1991-02-13 | USE OF ANALYZED TETRAHYDROPYRIDINE IGNESE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL ILLNESSES |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA921039B true ZA921039B (en) | 1992-09-30 |
Family
ID=6424901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA921039A ZA921039B (en) | 1991-02-13 | 1992-02-12 | New pharmaceutical use of fused tetrahydropyridine derivatives |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU1199092A (en) |
DE (1) | DE4104257A1 (en) |
IE (1) | IE920451A1 (en) |
IL (1) | IL100927A0 (en) |
WO (1) | WO1992014465A1 (en) |
ZA (1) | ZA921039B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2724384B1 (en) * | 1994-09-14 | 1999-04-16 | Cemaf | NOVEL 3,4-DIHYDRO BETA-CARBOLINE DERIVATIVES OF MELATONIN AGONISTS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
WO2000051998A1 (en) | 1999-03-02 | 2000-09-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as reversible inhibitors of cathepsin s |
CA2367138C (en) * | 1999-03-24 | 2010-10-05 | Alejandro M. S. Mayer | Anti-inflammatory uses of manzamines |
US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
NZ533358A (en) * | 2001-12-19 | 2007-05-31 | Lundbeck & Co As H | 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists |
TW201038569A (en) * | 2009-02-16 | 2010-11-01 | Abbott Gmbh & Co Kg | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
SG181498A1 (en) | 2009-12-04 | 2012-07-30 | Sunovion Pharmaceuticals Inc | Multicyclic compounds and methods of use thereof |
WO2018023072A2 (en) | 2016-07-29 | 2018-02-01 | Sunovion Pharmaceuticals, Inc. | Compounds and compositions and uses thereof |
EP3490607A4 (en) | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | Compounds and compositions and uses thereof |
EP3582815A1 (en) | 2017-02-16 | 2019-12-25 | Sunovion Pharmaceuticals Inc. | Methods of treating schizophrenia |
JP7191085B2 (en) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | Isochroman compounds and uses thereof |
US10815249B2 (en) | 2018-02-16 | 2020-10-27 | Sunovion Pharmaceuticals Inc. | Salts, crystal forms, and production methods thereof |
MX2021010880A (en) | 2019-03-14 | 2022-01-18 | Sunovion Pharmaceuticals Inc | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof. |
CN115734785A (en) | 2020-04-14 | 2023-03-03 | 桑诺维恩药品公司 | (S) - (4, 5-dihydro-7H-thieno [2,3-c ] pyran-7-yl) -N-methylmethanamine for the treatment of neurological and psychiatric disorders |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3021331A (en) * | 1959-07-20 | 1962-02-13 | Pfizer & Co C | Azabenzopyridocolines |
FR2455044A1 (en) * | 1979-04-26 | 1980-11-21 | Synthelabo | PYRIDO-INDOLES AND THEIR APPLICATION IN THERAPEUTICS |
IL86131A0 (en) * | 1987-04-24 | 1988-11-15 | Boehringer Ingelheim Kg | Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
DE3827727A1 (en) * | 1988-08-16 | 1990-02-22 | Boehringer Ingelheim Kg | ANALYZED TETRAHYDROPYRIDINE IGNESE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE OF SUCH CONNECTIONS FOR CARDIRO PROTECTION |
CA2000901A1 (en) * | 1988-10-21 | 1990-04-21 | Alexis A. Cordi | Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury |
JPH03109385A (en) * | 1989-09-22 | 1991-05-09 | Fujisawa Pharmaceut Co Ltd | New tricyclic amine compound and salt thereof |
AU6368090A (en) * | 1989-10-03 | 1991-04-11 | Warner-Lambert Company | Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity |
-
1991
- 1991-02-13 DE DE4104257A patent/DE4104257A1/en not_active Withdrawn
-
1992
- 1992-02-06 AU AU11990/92A patent/AU1199092A/en not_active Abandoned
- 1992-02-06 WO PCT/EP1992/000263 patent/WO1992014465A1/en active Application Filing
- 1992-02-12 IL IL100927A patent/IL100927A0/en unknown
- 1992-02-12 IE IE045192A patent/IE920451A1/en unknown
- 1992-02-12 ZA ZA921039A patent/ZA921039B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE920451A1 (en) | 1992-08-12 |
DE4104257A1 (en) | 1992-08-20 |
WO1992014465A1 (en) | 1992-09-03 |
IL100927A0 (en) | 1992-11-15 |
AU1199092A (en) | 1992-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103748A0 (en) | 2-substituted saccharin derivatives and pharmaceutical compositions containing them | |
EP0428268A3 (en) | Pharmaceutical phenylpyridone derivatives | |
IL88988A0 (en) | Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them | |
GB2255503B (en) | Improved use of ß2-bronchodilator drugs | |
NZ224129A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
EP0498268A3 (en) | 5-oxo-l-proline derivatives and pharmaceutical use thereof | |
NZ237191A (en) | 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions | |
NZ231487A (en) | Pyridin-2-yl piperazine derivatives and pharmaceutical compositions | |
ZA921039B (en) | New pharmaceutical use of fused tetrahydropyridine derivatives | |
IL103818A0 (en) | Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them | |
IL90639A (en) | Neplanocin derivatives and analogs and pharmaceutical compositions containing them | |
IL103747A0 (en) | Saccharin derivatives and pharmaceutical compositions containing them | |
NZ224130A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
NZ233013A (en) | Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions | |
NZ225387A (en) | Thienoimidazole derivatives and pharmaceutical compositions | |
NZ230927A (en) | Substituted piperazine derivatives and therapeutic compositions | |
NZ228403A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
NZ225383A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
NZ239186A (en) | Substituted 2-(9-fluorenonyl)-carbapenem derivatives and pharmaceutical | |
IL102539A0 (en) | Preparation of 17beta-substituted-4-aza 5alpha-androstan-3-one derivatives | |
NZ209447A (en) | Heterocyclic aminocyclopentane derivatives and pharmaceutical compositions | |
NZ241331A (en) | 3-phenyl-2-alkenamide derivatives and pharmaceutical compositions thereof | |
NZ228281A (en) | Tricyclo-amine derivatives and pharmaceutical compositions | |
ZA945651B (en) | Use of benzenesulphonzlindole derivatives for the preparation of medicines | |
NZ224997A (en) | Cephalosporin derivatives and pharmaceutical compositions |